Kasiani C Myers, MD¹, Jie He, MS^2*, Ben Goldberg, MS^2*, Christopher R. Reilly, MD³, Yang Wan, MD PhD^4*, Xiaofan Zhu, MD^4,5,6, Simone Cesaro, MD^7*, Marco Cipolli, MD^8*, Alison A. Bertuch, MD, PhD^9,10, Candelaria O'Farrell, MD^11,12, Kenichiro Watanabe, MD, PhD^13*, Antonis Kattamis, MD¹⁴, Polyxeni Delaporta, MD^15*, Melanie Cotter, MB¹⁶, Eoghan Dunlea, MD^17,18*, Taizo A. Nakano, MD¹⁹, Amy E. Geddis, MD, PHD^20*, Karyn Brundige, MSN, CPNP^21*, Ian Atkinson^22*, Katherine Coyne^21*, Sara Loveless^1*, Leah Cheng^21*, Edie Weller, PhD^2,23*, Jean Donadieu²⁴ and Akiko Shimamura, MD, PhD²⁵

¹Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
²Biostatistics and Research Design Center at BCH and Department of Pediatrics at Harvard Medical School, Boston, MA
³Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁴Department of Pediatric Hematology and Oncology, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences& Peking Union Medical College, Tianjin, China
⁵Childhood Bone Marrow Failure Diseases Register of China Alliance for Blood Diseases, Tianjin, China
⁶Tianjin Institutes of Health Science, Tianjin 301600, China
⁷Pediatric Hematology-Oncology, Azienda Ospedaliera Universitaria Integrata, Verona, Italy
⁸Cystic Fibrosis Center, Azienda Ospedaliera Universitaria Integrata, Verona, Italy
⁹Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, TX
¹⁰Texas Children's Hospital, Houston, TX
¹¹Texas Children’s Hospital, Houston, TX
¹²Texas Children's Hospital / Baylor College of Medicine, Houston, TX
¹³Department of Hematology and Oncology, Shizuoka Children's Hospital, Shizuoka, SHZ, JPN
¹⁴Division of Pediatric Hematology-Oncology, First Department of Pediatrics, "Aghia Sophia" Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece
¹⁵Thalassemia Unit, First Department of Pediatrics, National and Kapodistrian University of Athens, Athens, Greece
¹⁶Trinity College, Dublin, Ireland
¹⁷Trinity College, Department of Paediatrics, Dublin, Ireland
¹⁸Children's Health Ireland, Department of Haematology, Dublin, Ireland
¹⁹Children's Hospital Colorado, Denver, CO
²⁰Cancer and Blood Disorders Center, Seattle Children's Hospital, Seattle, WA
²¹Department of Pediatric Hematology/Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA
²²Dana-Farber and Boston Children’s Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA
²³Harvard Medical School, Department of Pediatrics, Boston, MA
²⁴French Reference Center for Histiocytosis, Department of Pediatric Hematology and Oncology, Trousseau Hospital, AP-HP, Sorbonne Université, Paris, France
²⁵Boston Children's Hospital, Boston, MA

Enrico Attardi, MD^1,2*, Nathan Gray, PA-C^1*, Sara Lewis, MS, CGC^1*, Michelle Boals, NP^1*, Peng Li, MD, PhD³, Erica F. Andersen, PhD, FACMG³, Jian Zhao, PhD^3*, Lucilla Pizzo, PhD^3*, Bo Hong, MD, FACMG³, Passant Shaker, MD, CGC^1*, Rohith Jesudas, MD^1*, Lili Kotmayer, MD, PhD^1*, Sushree Sahoo, PhD⁴, Richa Sharma, MD¹, Georgios E. Christakopoulos, MD^1*, Alyssa Kennedy, MD, PhD^1*, Senthil Velan Bhoopalan, MD, PhD^1*, Clifford M. Takemoto, MD¹, Maria Teresa Voso, MD⁵ and Marcin Wlodarski, MD, PhD⁴

¹Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN
²Department of Biomedicine and Prevention, PhD in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Roma, Italy
³ARUP Laboratories, Salt Lake City, UT
⁴St. Jude Children's Research Hospital, Memphis, TN
⁵Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy

Gary Kupfer¹, Paymon Doroodian^2*, Jian Li^3*, Erica Golemis^4*, Paul Young^5*, Emily Stahl^6*, Arvin Nagarajan^6*, Patrick Sung^7* and Barbara Burtness^8*

¹Department of Oncology, Georgetown University, Washington, DC
²Georgetown University, Washington
³Chengdu Universtity, Sichuan, China
⁴Fox Chase Cancer, Philedelphia, PA
⁵Rockefeller University, New york, NY
⁶Georgetown University, Washington, DC
⁷UT Health San Antonio, San Antonio, TX
⁸Yale University, New Haven, CT

Shigeki Hirabayashi, MD, PhD¹, Momoka Tsuruhara^1*, Kyoko Fukushi^1*, Shoko Tarumoto^2*, Moe Shinagawa^2*, Yuichiro Semba, MD, PhD^1*, Takuya Yamamoto, PhD^2,3,4*, Yuichi Shiraishi, PhD^5*, Kiyoko Miyata, PhD^1*, Taro Tsujimura, PhD^2* and Takahiro Maeda, MD, PhD¹

¹Division of Precision Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
²Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan
³Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, JPN
⁴Medical-risk Avoidance based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP), Kyoto, Japan
⁵Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan

Vinicius S. Carvalho, MSc^1*, Flávia S. Donaires, PhD^2*, Maria Florencia Tellechea, PhD^3*, Barbara A. Santana, PhD^4*, Guy Sauvageau, MD/PhD⁵ and Rodrigo T. Calado, MD, PhD⁶

¹Ribeirao Preto School of Medicine, University of Sao Paulo, Ribeirao Preto, Brazil
²Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, SP, BRA
³Institute for Research in Immunology and Cancer, University of Montreal, Montreal, QC, Canada
⁴University of Sao Paulo, Ribeirao Preto, BRA
⁵Universite de Montreal, Montreal, QC, CAN
⁶University of Sao Paulo, Ribeirão Preto, Brazil

Maria Gabarrós-Subirà^1*, Carlos Pérez Míguez^2*, Sandra Novoa Jáuregui, MD^3*, Jose Angel Díaz-Arias^4*, Tzu Hua Chen, MD^5*, Sara Torres-Esquius, MSc^6*, Araceli Sama-Barroso^7*, Helena Pomares^8*, Teresa Ezponda^9*, Montserrat Arnan, MD, PhD^10*, Maria Diez-Campelo, MD, PhD^11*, Davide Crucitti^12*, Ana Alfonso Pierola, MD, PhD^13*, Mónica Del Rey^14*, Laura Palomo^15*, Francesc Bosch, MD, PhD¹⁶, David Valcárcel Ferreiras^17*, Julia Montoro^18*, Adrian Mosquera Orgueira, MD, PhD^19* and Andres Jerez, MD, PhD^16*

¹Department of Hematology, University Hospital Vall d’Hebron, Barcelona, España., Barcelona, Spain
²Computational Hematology & Genomics Group (GrHeCo-Xen), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain
³Hematology Department, Vall d'Hebron University Hospital, University Autònoma of Barcelona (UAB), Barcelona, Spain
⁴Department of Hematology, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain
⁵Hematology and Medical Oncology Department, University Hospital Morales Meseguer. CRH-IMIB, Murcia, Spain
⁶Vall d'Hebron University Hospital, Barelona, AL, Spain
⁷Department of hematology, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain
⁸Clinical Hematology Department, ICO-Hospitalet, Hospital Durán i Reynals. IDIBELL, Barcelona., Barcelona, Spain
⁹Department of Oncology-Hematology, Centro de Investigación Médica Aplicada (CIMA), Navarra university-IDISNA. Centro de Investigación Biomédica en Red de Cáncer, CIBERONC. Clínica Universidad de Navarra, Pamplona, ESP
¹⁰Hematology Department, Institut Català d'Oncologia - Hospital Duran I Reynals, Hospitalet de Llobregat, Spain
¹¹University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Department of Hematology - Hospital Universitario de Salamanca, Salamanca, Spain
¹²Health Research Institute of Santiago de Compostela (IDIS), Santiago De Compostela, Spain
¹³Hematology and Cell Therapy Department, Clinica Universidad de Navarra, Instituto de Investigaciones Sanitarias de Navarra (IdiSNA), Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain
¹⁴Department of Hematology, Salamanca-IBSAL University Hospital, Salamanca, Spain
¹⁵CO-Hospital Germans Trias i Pujol, Barcelona, Spain
¹⁶Department of Hematology, Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, Barcelona, Spain
¹⁷Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, University Autonoma of Barcelona (UAB), Barcelona, Spain
¹⁸Hospital Universitari Vall d'Hebron, Barcelona, Spain
¹⁹University Hospital of Santiago de Compostela, Department of Hematology, IDIS, SANTIAGO DE COMPOSTELA, Spain

Sara Torres-Esquius, MSc^1*, Guillermo Ramil López, MD^2*, Maria Gabarros Subira^3*, Pamela Acha^4*, Sandra Novoa Jáuregui, MD^5*, Marta Pratcorona, MD, PhD^2*, Silvia Saumell, MD, PhD^6*, David Valcarcel, MD, PhD⁷, Andres Jerez, MD, PhD^8* and Maria Julia Montoro, MD, PhD^9*

¹Vall d'Hebron University Hospital, Barelona, AL, Spain
²Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
³Department of Hematology, Vall d'Hebron University Hospital, Barcelona, Spain / España, Spain
⁴Experimental Hematology, Hospital Universitario Vall d’Hebrón, Institut d’Oncologia Vall d’Hebrón (VHIO), Barcelona, Spain
⁵Department of Hematology, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain
⁶Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain
⁷Department of Hematology and Oncology, Hospital Universitario Vall d'Hebron, Barcelona, Spain
⁸Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
⁹Experimental Hematology. Hematology Department Vall d´Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d’Hebrón, BARCELONA, Spain

Alexandra Prosser, MD¹, Irina Pushel, PhD^2*, Chris Seidel, PhD^3*, Jacqelyn Nemechek, PhD^1*, Molly Leyda^1*, Priyanka Prem Kumar^4*, Jay Vivian, PhD^4*, Jennifer Gerton^3* and John M. Perry, PhD¹

¹Division of Hematology/Oncology/Bone Marrow Transplant, Children's Mercy Kansas City, Kansas City, MO
²Genomic Medicine Center, Children's Mercy Kansas City, Kansas City, MO
³Stowers Institute for Medical Research, Kansas City, MO
⁴Division of Clinical Genetics, Children's Mercy Kansas City, Kansas City, MO